May 15th In NYC: CannaStocks2019 Q1 Investor Conference

CaptureCannaStocks2019 Q1 Investor Conference takes place today (May 15, 2019) in New York City. 

For Investment Professionals, Accredited Investors, and Financial Media

8AM-6PM – Reservations required. Send an INQUIRY to bruce@cannastocks2019.com

OTC Markets Group, 300 Vesey Street, NYC 10282

Featuring: Presentations, Q-and-A, and Panels with select OTC Markets Group leaders in the Cannabis sector. Themes to be explored: innovation, consolidation, international expansion, specialization, legalities, and advertising. 

Companies presenting: KushCo Holdings, Acreage Holdings, MariMed, Emerald Bioscience, OrganiGram Holdings, Sproutly, Emerald Health Therapeutics, Supreme Cannabis Company, Canopy Rivers, 1933 Industries, AXIM Biotechnologies, GSRX Industries, and New Frontier Data will provide an industry overview about current market trends. Investors unable to attend can watch a video webcast of the conference.


To pre-register for the webcast, click HERE:
https://protect-us.mimecast.com/s/_tFRCmZEyPCjvvoruG4-KO?domain=tinyurl.com

There is no charge for access to the webcast. Those unable to view the webcast on May 15 will find it archived and for later viewing on the Virtual Investor Conferences website.

Study: CBD Dosing Relieves Symptoms In Patients With Anxiety Disorders

COLORADO: The daily administration of CBD is associated with sustained symptomatic relief in patients diagnosed with anxiety disorders, according to the results of a case series published in The Permanente Journal.

Investigators at the University of Colorado, Denver and Colorado State University assessed the adjunctive use of low daily doses of CBD (typically 25mg capsules) over a three-month period in a cohort of patients diagnosed with either sleep or anxiety disorders.

Researchers reported that patients experienced a “mild improvement” in sleep scores, and a larger “more sustained response to anxiety.” They also reported that “CBD appears to be better tolerated than routine psychiatric medications.”

Authors acknowledged that the therapeutic doses used in the study were far lower than those typically associated with anxiolytic action in prior clinical trials.

They concluded: “Anxiety scores decreased fairly rapidly, and this decrease was sustained during the study period. … Randomized and controlled trials are needed to provide definitive clinical guidance.”


For more information, contact Paul Armentano, NORML Deputy Director, at: paul@norml.org. Full text of the study, “Cannabidiol in anxiety and sleep: A large case series,” appears in The Permanente Journal.

MedMen Acquires New York Medical Marijuana Company

CALIFORNIA: MedMen, a Los Angeles-based cannabis management and investment firm, announced today that it has acquired Bloomfield Industries, Inc., one of only five Registered Organizations licensed to operate a medical marijuana business in the State of New York. The acquisition provides MedMen with the opportunity to apply its operational expertise and institutional best practices to one of the largest potential medical marijuana markets in the country.

The transaction occurred through a sale of Bloomfield Industries’ capital stock, thereby allowing Bloomfield Industries to remain as the Registered Organization under the New York State Public Health Law.

Since October of 2016, MedMen has been working with Bloomfield Industries to help streamline operations, improve production capabilities and provide a better overall patient experience. MedMen’s post transaction plan includes the development of a state-of-the-art cultivation and production facility in Utica, as well as applying MedMen’s industry-leading retail model to Bloomfield’s current three pharmacies in Syracuse, Buffalo and Lake Success. Bloomfield Industries also intends to roll out a new pharmacy in Manhattan, making it one of only two medical marijuana pharmacies operating in the city.

“New York is critical to our broader strategy,” said Adam Bierman, co-founder and chief executive officer of MedMen. “We are talking about the fourth most populous state in the country and home to one of the largest, most densely populated cities in the world. We have the opportunity to serve roughly a fifth of that market, perhaps more and we are very excited about this opportunity.”

Ninth Circuit Rules Marijuana Card Holders May Not Own Firearms

NEVADA: Last Wednesday a three-judge panel of the Ninth Circuit Court of Appeals upheld a lower court’s decision that holding a marijuana card precludes its owner from keeping and bearing arms. In the process, the panel threw out the First, Second, and Fifth Amendment rights.

Rowan Wilson, a Nevada resident who held a state-issued marijuana card but didn’t use the weed, tried to purchase a firearm from Custom Firearms and Gunsmithing in Moundhouse, Nevada. She applied for the card to show her support for the freedom of people to make their own decisions about what they might or might not imbibe or inhale. It was a political statement only. It became personal when she tried in October 2011 to purchase a firearm for personal protection.

She was confronted with Question 11e on the required federal disclosure Form 4473 issued by the ATF, which reads: “Are you an unlawful user of, or addicted to, marijuana or any depressant, narcotic drug, or any other controlled substance? Yes or No.” She showed the question to the gun shop owner, who knew that she had a card, and he denied her request to purchase the firearm. It was based not only on federal laws that still make marijuana users criminals, but on an “open letter” the ATF sent to all firearm dealers holding that mere possession of the marijuana registry card was enough to allow them to prevent a potential buyer from completing the sale. That letter stated, in part:

[Anyone] who uses or is addicted to marijuana, regardless of whether his or her state has passed legislation authorizing marijuana use for medicinal purposes — is prohibited by federal law from possessing firearms or ammunition.

Such persons should answer “yes” to question 11.e. on ATF Form 4473 … and you may not transfer firearms or ammunition to them.

Further, if you are aware that the potential transferee is in possession of a card authorizing the possession and use of marijuana under State law, then you have “reasonable cause to believe” that the person is an unlawful user of a controlled substance.

As such, you may not transfer firearms or ammunition to the person, even if the person answered “no” to question 11.e. on ATF Form 4473.

 

California Legislature Sends Marijuana Regulations To Gov. Brown

CALIFORNIA: California lawmakers on Friday passed wide-ranging proposals for regulating the medical marijuana industry, which would lay groundwork for state control of the cultivation and sale of cannabis in the event that voters legalize recreational use of the drug next year.

The package of bills, crafted in a compromise between legislative leaders and the governor, would create a new state agency to license medical cannabis dispensaries and require marijuana growers to adhere to the laws and regulations imposed on other farmers, including restrictions on pesticides, insecticides and water use.

“This is better than what we have, the status quo, which is the Wild West,” said Sen. Mike McGuire (D-Healdsburg), one of the architects of the deal.

Recreational Use Of Marijuana Becomes Legal In D.C.

DISTRICT OF COLUMBIA:  Recreational use of marijuana becomes legal in the nation’s capital Thursday.

In November, District of Columbia voters approved Initiative 71, which legalized recreational pot use. The District joins Alaska, Colorado and Washington state in making the drug legal.

As of 12:01 a.m. Thursday, people 21 and older can:

• Possess 2 ounces or less of marijuana;

• Share 1 ounce or less with another person at least 21 years old, as long as no money, goods or services change hands;

• Cultivate up to six marijuana plants, but have no more than three mature plants, in their primary home; and

• Use marijuana on private property.

Committee On Drugs And The Law Present The Future of Marijuana Law in New York City Wed 1/28/15

NEW YORK: On Wednesday, January 28, 2015, 6:30pm – 8:30pm, the Committee on Drugs and the Law and the New York City Affairs Committee will host an open discussion of the past, present and possible futures of cannabis law in New York City.

Featured panelists include Stephen Levin, New York City Council, District 33; Jumaane D. Williams, New York City Council, District 45; and Nitin Savur, Deputy Chief of Trial Division in Charge of Criminal Courts, Office of the New York County District AttorneyModerator: Patricia Salkin, Dean and Professor of Law, Touro Law Center

Public attitudes and laws governing the use of cannabis have been changing fast and creating challenges and opportunities for policymakers at the state and local level.

The changes in New York State during 2014 were especially great. A new statute legalized certain limited uses of cannabis for medical purposes and the Department of Health has released draft regulations for public comment. After attempting in 2012 to convince the State legislature to expand the scope of New York’s cannabis decriminalization statute, New York County District Attorney Cyrus Vance endorsed the de Blasio administration’s announcement that the New York City Police Department will issues summonses for possession of personal-use amounts of cannabis open to public view instead of making arrests. Earlier, Kings County District Attorney Kenneth Thompson announced that his office will not prosecute first-time offenders for possession of personal-use amounts.

Meanwhile, if proposed legislation that would regulate cannabis like alcohol succeeds, it will require adjustments to state and local law far broader than those necessary to create the newly legalized medical-use-only cannabis market.

The event sponsors include the Committee on Drugs and the Law and the New York City Affairs Committee.